Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: Dementia

International Psychogeriatrics

Volumn 28, Issue 9, 2016, Pages 1409-1424

  Burke, Shanna L ^a   Maramaldi, Peter ^b,c,d   Cadet, Tamara ^b,c   Kukull, Walter ^e  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b SIMMONS COLLEGE   (United States)

^c HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

apolipoprotein E; dementia; depression; Key words Alzheimer's disease; sleep disturbance

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; ALZHEIMER DISEASE; APOLIPOPROTEIN E GENE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SLEEP DISORDER; SOCIAL PSYCHOLOGY; AGED; DEMENTIA; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; DEMENTIA; DEPRESSION; FEMALE; GENE-ENVIRONMENT INTERACTION; GENOTYPE; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SLEEP WAKE DISORDERS;

EID: 84961927153     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610216000405     Document Type: Article

References (69)

1. Aboud O., Mrak R. E., Boop F., and Griffin S. T. (2012). Apolipoprotein epsilon 3 alleles are associated with indicators of neuronal resilience. BMC Medicine, 10, 35-44. doi: 10.1186/1741-7015-10-35
2. Alzheimer?s Association (2015). Alzheimer?s disease facts, and figures. Alzheimer?s & Dementia, 11, 332-384. doi: http://dx.doi.org/10.1016/j.jalz.2015.02.003
3. American Psychiatric Association (1994). Diagnostic, and Statistical Manual of Mental Disorders 4th edn. Washington, DC: American Psychiatric Publishing
4. American Psychiatric Association (2013). Diagnostic, and Statistical Manual of Mental Disorders 5th edn. Arlington, VA: American Psychiatric Publishing
5. Anderson K. N., and Bradley A. J. (2013). Sleep disturbance in mental health problems, and neurodegenerative disease. Nature & Science of Sleep, 561-575. doi: 10.2147/NSS.S34842
6. Arnone D., et al. (2013). State dependent changes in hippocampal grey matter. Molecular Psychiatry, 18, 1265-1272
7. Ballard C. Massey H., Lamb H., and Morris C. (1997). Apolipoprotein E: non-cognitive symptoms, and cognitive decline in late onset Alzheimer?s disease. Journal of Neurology, Neurosurgery & Psychiatry, 63, 273-273. doi: 10.1136/jnnp.63.2.273b
8. Barnes D., and Yaffe K. (2011). The projected effect of risk factor reduction on Alzheimer?s disease prevalence. Lancet Neurology, 10, 819-828. doi: 10.1016/S1474-4422(11)70145-4
9. Bateman R., et al. (2012). Clinical, and biomarker changes in dominantly inherited Alzheimer?s disease. New England Journal of Medicine, 367, 795-804
10. Belsky D. W., Moffitt T. E., and Caspi A. (2013). Genetics in population health science: strategies, and opportunities. American Journal of Public Health 103(S1), S73-S83
11. Brainerd C. J., Reyna V. F., Petersen R. C., Smith G. E., and Taub E. S. (2011). Is the apolipoprotein e genotype a biomarker for mild cognitive impairment?. Findings from a nationally representative study. Neuropsychology, 25, 679-689. doi: 10.1037/a0024483
12. Brainerd C. J., et al. (2013). The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer?s dementia: findings from a nationally representative study. Neuropsychology, 27, 86-94. doi: 10.1037/a0030855
13. Buckley J. D. (1984). Additive, and multiplicative models for relative survival rates. Biometrics, 40, 51-62
14. Cantillon M., Barker W., Harwood D., Mullan M., and Duara R. (1996). Phenotype of depression in Alzheimer?s disease (AD) with APOE genotype. Biological Psychiatry, 39, 661
15. Caraci F., Copani A., Nicoletti F., and Drago F. (2010). Depression, and Alzheimer?s disease: neurobiological links, and common pharmacological targets. European Journal of Pharmacology, 626, 64-71
16. Centers for Disease Control, and Prevention (2013, March). Underlying mortality data provided by national center for health statistics. Retrieved October 27, 2013, from http://www.cdc.gov/nchs/data/databriefs/db116.pdf
17. Chui H. C., Zheng L., Reed B. R., Vinters H. V., and Mack W. J. (2012). Vascular risk factors, and Alzheimer?s disease: are these risk factors for plaques, and tangles or for concomitant vascular pathology that increases the likelihood of dementia?. An evidence-based review. Alzheimer?s Research, and Therapy, 4, 1-13. doi: 10.1186/alzrt98
18. Corder E. H., et al. (1993). Gene dose of apolipoprotein E type allele, and the risk of Alzheimer?s disease in late onset families. Science, 261, 921-923
19. Corder E. H., et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7, 181-184
20. Cox D. R. (1972). Regression models, and life-tables. Journal of the Royal Statistical Society, Series B, 34, 187-220
21. Cummings J. L. (1997). The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology 48, S10-S16
22. de-Almada B. V. P., et al. (2012). Protective effect of the APOE-e3 allele in Alzheimer?s disease. Brazilian Journal of Medical, and Biological Research, 45, 8-12
23. de Oliveira F. F., Ferreira Bertolucci P. H., Chen E. S., and Smith M. C. (2014). Assessment of risk factors for earlier onset of sporadic Alzheimer?s disease dementia. Neurology India, 62, 625-630. doi: 10.4103/0028-3886.149384
24. Donix M., Small G. W., and Bookheimer S. Y. (2012). Family history, and APOE-4 genetic risk in Alzheimer?s disease. Neuropsychological Review, 22, 298-309. doi: 10.1007/s11065-012-9193-2
25. Efron B. (1977). The efficiency of Cox?s likelihood function for censored data. Journal of the American Statistical Association, 72, 557-565
26. Farrer L. A., et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype, and Alzheimer disease: a meta-analysis. JAMA, 278, 1349-1356
27. Fortune D. A., Lang R., Cook S., and Byrd G. S. (2013). African Americans, and Alzheimer?s disease: role of health educators in addressing this silent epidemic. American Journal of Health Studies, 28, 92-100
28. Ghebranious N., et al. (2011). A pilot study of gene/gene, and gene/environment interactions in Alzheimer disease. Clinical Medicine & Research, 9, 17-25. doi: 10.3I2l/cmr.20I0.894
29. Gil-Bea F. J., et al. (2010). HPA axis dysregulation associated to apolipoprotein e4 genotype in Alzheimer?s disease. Journal of Alzheimer?s Disease, 22, 829-838. doi: 10.3233/JAD-2010-100663
30. Harwood D. G., Barker W.W., Ownby R. L., Mullan M., and Duara R. (2004). No association between subjective memory complaints, and apolipoprotein E genotype in cognitively intact elderly. International Journal of Geriatric Psychiatry, 19, 1131-1139. doi: 10.1002/gps.1193
31. Hollingworth P., Harold D., Jones L., Owen M. J., and Williams J. (2011). Alzheimer?s disease genetics: current knowledge, and future challenges. International Journal of Geriatric Psychiatry, 26, 793-802. doi: 10.1002/gps.2628
32. Hollingworth P., et al. (2006). Four components describe behavioral symptoms in 1, 120 individuals with late-onset Alzheimer?s disease. Journal of the American Geriatrics Society, 54, 1348-1354
33. Kaufer D. I., et al. (2000). Validation of the NPI-Q: a brief clinical form of the neuropsychiatric inventory. The Journal of Neuropsychiatry, and Clinical Neurosciences, 12, 233-239
34. Kleinbaum D. G., and Klein M. (2012). Survival Analysis: A Self-Learning Text 3rd edn. New York: Springer
35. Kumar A., and Chanana P. (2014). Sleep reduction: a link to other neurobiological diseases. Sleep, and Biological Rhythms, 12, 150-161. doi: 10.1111/sbr.12066
36. Lee H. J., and Dugan E. (2015). How large is the gap between self-report, and assessed mental health, and does it impact older adult mental health service utilization?. Journal of Gerontological Social Work, 58, 3-19. doi: 10.1080/01634372.2014.919978
37. Lim A., Yu L., Kowgier M., Schneider J., Buchman A., and Bennett D. (2013). Modification of the relationship of the apolipoprotein E ϵ4 allele to the risk of Alzheimer disease, and neurofibrillary tangle density by sleep. JAMA Neurology, 70, 1544-1551. doi: 10.1001/jamaneurol.-.4215
38. López-León S. S., et al. (2008). Meta-analyses of genetic studies on major depressive disorder. Molecular Psychiatry, 13, 772-785. doi: 10.1038/sj.mp.4002088
39. Luciano M., et al. (2015). Current versus lifetime depression, APOE variation, and their interaction on cognitive performance in younger, and older adults. Psychosomatic Medicine, 77, 480-492. doi: 10.1097/PSY.0000000000000190
40. Lyketsos C. G. andOlin J. (2002). Depression in Alzheimer?s disease: overview, and treatment. Biological Psychiatry, 52, 243-252
41. Marques S. F., Oliveira C. R., Outeiro T. F., and Pereira C. F. (2010). Alzheimer?s disease: the quest to understand complexity. Journal of Alzheimer?s Disease, 21, 373-383. doi: 10.3233/JAD2010100303
42. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E. M. (1984). Clinical diagnosis of Alzheimer?s disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health, and human services task force on Alzheimer?s disease. Neurology, 34, 939-944
43. McKhann G., et al. (2011). The diagnosis of dementia due to Alzheimer?s disease: recommendations from the national institute on aging-Alzheimer?s association workgroups on diagnostic guidelines for Alzheimer?s disease. Alzheimer?s & Dementia, 7, 263-269. doi: 10.1016/j.jalz.2011.03.005
44. Mendelsohn A. R., and Larrick J. W. (2013). Sleep facilitates clearance of metabolites from the brain: glymphatic function in aging, and neurodegenerative diseases. Rejuvenation Research, 18, 518-523. doi: 10.1089/rej.2013.1530
45. Meng X., and D?Arcy C. (2013). Apolipoprotein E gene, environmental risk factors, and their interactions in dementia among seniors. International Journal of Geriatric Psychiatry, 28, 1005-1014. doi: 10.1002/gps.3918
46. Morris J. C., et al. (2006). The uniform data set (UDS): clinical, and cognitive variables, and descriptive data from Alzheimer?s disease centers. Alzheimer Disease, and Associated Disorders, 20, 210-216
47. Multhammer M., Michels A., Zintl M., Mendoza M. C., and Klünemann H. H. (2014). A large ApoE ϵ4/ϵ4 homozygous cohort reveals no association with Parkinson?s disease. Acta Neurologica Belgica, 114, 25-31
48. National Alzheimer?s Coordinating Center (2010). The UDS study population. Retrieved from: https://www.alz.washington.edu/WEB/study-pop.html
49. Nikodemova M., Finn L., Mignot E., Salzieder N., and Peppard P. E. (2013). Association of sleep disordered breathing, and cognitive deficit in APOE 4 carriers. Sleep, 36, 873-880. doi: 10.5665/sleep.2714
50. Osorio R. S., et al. (2014). The interaction between sleep-disordered breathing, and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer?s disease in cognitively normal elderly individuals. Neurobiology of Aging, 35, 1318-1324. doi: 10.1016/j.neurobiolaging.2013.12.030
51. Peavy G. M., et al. (2007). The effects of prolonged stress, and APOE genotype on memory, and cortisol in older adults. Biological Psychiatry, 62, 472-478
52. Pistacchi M., Gioulis M., Contin F., Sanson F., and Marsala S. Z. (2014). Sleep disturbance, and cognitive disorder: epidemiological analysis in a cohort of 263 patients. Journal of the Neurological Sciences. doi: 10.1007/s10072-014-1870-x
53. Portney L. G., and Watkins M. P. (2009). Foundations of Clinical Research: Applications to Practice 3rd edn. Upper Saddle River, NJ: Pearson Education, Inc
54. Qiu C., Xu W., Winblad B., and Fratiglioni L. (2010). Vascular risk profiles for dementia, and Alzheimer?s disease in very old people: a population-based longitudinal study. Journal of Alzheimer?s Disease, 20, 293-300. doi: 10.3233/JAD-2010-1361
55. Reitz C., Tang M. X., Schupf N., Manly J. J., Mayeux R., and Luchsinger J. A. (2010). A summary risk score for the prediction of Alzheimer disease in elderly persons. Archives of Neurolology, 67, 835-841. doi: 10.1001/archneurol.2010.136
56. Saunders A., et al. (1993). Association of apolipoprotein E allele epsilon 4 with late-onset familial, and sporadic Alzheimer?s disease, Neurology 43, 1467-1472
57. Schipper H. M. (2011). Apolipoprotein E: implications for AD neurobiology, epidemiology, and risk assessment. Neurobiology of Aging, 32, 778-790. doi: 10.1016/j.neurobiolaging.2009.04.021
58. Segal A. Z. (2013). Poor sleep quality may predict preclinical Alzheimer?s disease. Neurology Alert, 31, 86-88
59. Sheline Y. I., Gado M. H., and Kraemer H. C. (2003) Untreated depression, and hippocampal volume loss. American Journal of Psychiatry, 160, 1516-1519
60. Sperling R. A., et al. (2011). Toward defining the preclinical stages of Alzheimer?s disease: recommendations from the national institute on aging-Alzheimer?s association workgroups on diagnostic guidelines for Alzheimer?s disease. Alzheimer?s & Dementia, 7, 280-292. doi: 10.1016/j.jalz.2011.03.003
61. Spira A. P., et al. (2013). Self-reported sleep, and β-amyloid deposition in community-dwelling older adults. JAMA Neurology, 70, 1537-1543
62. StataCorp (2015). Stata Statistical Software: Release 14. College Station, TX: StataCorp LP
63. Talbot C., Lendon C., Craddock N., Shears S., Morris J. C., and Goate A. (1994). Protection against Alzheimer?s disease with APOE epsilon 2. Lancet, 343, 1432-1433
64. Thies W., and Bleiler L. (2013). 2013 Alzheimer?s disease facts, and figures. Alzheimer?s & Dementia: The Journal of the Alzheimer?s Association, 9, 208-245. doi: 10.1016/j.jalz.2013.02.003
65. Virta J., et al. (2013). Midlife sleep characteristics associated with late life cognitive function. Sleep, 36, 1533-1541. doi: 10.5665/sleep.3052
66. Weintraub S., et al. (2009). The Alzheimer?s disease centers? uniform data set (UDS): the neuropsychological test battery. Alzheimer Disease, and Associated Disorders, 23, 91. doi: 10.1097/WAD.0b013e31819c7dd
67. Weldemichael D. A., and Grossberg G. T. (2010). Circadian rhythm disturbances in patients with Alzheimer?s disease: a review. International Journal of Alzheimer?s Disease, 2010, 1-9. doi: 10.4061/2010/716453
68. Xie L., et al. (2013). Sleep drives metabolite clearance from the adult brain. Science, 342, 373-377. doi: 10.1126/science.1241224
69. Yesavage J. A., et al. (2004). Sleep/Wake disruption in Alzheimer?s disease: APOE status, and longitudinal course. Journal of Geriatric Psychiatry & Neurology, 17, 20-24. doi: 10.1177/0891988703261994